Ann: Growth Initiatives and Performance Metrics, page-3

NPAT or EBITDA isn't that important at this stage. They're in recovery and growth mode. If they can show they are cutting costs, whilst spending on growth and that this is translating to increased Revenues, that could be enough to make the stock rise to 3c. The market is smart enough to work out that if you have revenue growth but spending on growth is increasing then when the spending ceases, that's likely to translate into NPAT.